Tagged with R

Global In 2022 global healthcare will continue to feel the effects of the pandemic and although COVID-19 has become less virulent, with the global death rate down to 0.4 percent from an initial peak of about three percent, new variants are still set to emerge this year. At the Economist Intelligence…

Italy Bormioli Pharma’s Andrea Lodetti outlines the company’s evolution towards becoming an international leader in the pharma and primary packaging business, COVID-related business impacts, the shift towards localised manufacturing, and the importance of earlier and deeper collaboration between pharma companies and packaging providers.   I hope that the cooperation between packaging…

Italy Speaking exclusively to PharmaBoardroom, Pierluigi Antonelli outlines Angelini Pharma’s progress in transforming from a traditional, Italy-focused, and family-owned firm into a true European innovator. Antonelli outlines the potential impact of Angelini’s USD 960 million Arvelle acquisition, why he is optimistic about success in the challenging brain health space, and how…

MEA The Middle East and Africa (MEA) medtech market is expected to grow from a value of USD 16.6 billion in 2019 to USD 21.8 billion at a CAGR of 3.6 percent by 2027, according to Business Market Insights. Read on for five crucial trends impacting MEA medtech and how the…

France The top ten pharma companies in France for 2021. Sanofi leads the pack with EUR 2.367 billion in turnover, followed by Servier (EUR 2.284 billion) and Janssen (EUR 1.175 billion).

Spain Almirall CEO Gianfranco Nazzi dives into the new strategic focus of the global biopharmaceutical company with HQ in Barcelona as it seeks to serve the European medical dermatology market. The Italian executive reflects on his first few months at the helm, the cumulative experience of Almirall’s management board, the global…

UAE Maher Abouzeid gives his expert insights into the key trends underway in the Middle Eastern medtech industry, including growing numbers of PPPs, the rise of the digital hospital post-COVID, and greater interaction with the pharma sector.   The positive side of COVID is that it helped accelerate the transformation of…

Saudi Arabia IQVIA Vice President and General Manager Saudi Arabia & Egypt Mohamed Mostafa gives his expert insights into the transformation of the Saudi pharma market in recent years, covering everything from procurement to regulatory, reimbursement, clinical trials, localisation, health economics, and digitalisation. Mostafa also outlines how IQVIA has adapted its Saudi…

Pharma Legal Handbook A brief legal overview of the situation regarding the regulation, pricing and reimbursement of pharmaceuticals in Brazil.  Prepared in association with Trench, Rossi e Watanabe one of Brazil’s most prestigious law firms, this is an extract from The Pharma Legal Handbook: Brazil, which can be purchased for GBP 119, here.…

Pharma Legal Handbook The requirements for conducting preclinical and clinical trials in Brazil.  Prepared in association with Trench, Rossi e Watanabe one of Brazil’s most prestigious law firms, this is an extract from The Pharma Legal Handbook: Brazil, which can be purchased for GBP 119, here.   1. Are clinical trials required to be conducted locally…

Pharma Legal Handbook Everything you need to know about the marketing, manufacturing, packaging & labeling and advertising of pharmaceuticals in Brazil. Prepared in association with Trench, Rossi e Watanabe one of Brazil’s most prestigious law firms, this is an extract from The Pharma Legal Handbook: Brazil, which can be purchased for GBP 119, here.  …

Pharma Legal Handbook A guide to the state-of-play regarding traditional medicines and over-the-counter (OTC) products in Brazil. Prepared in association with Trench, Rossi e Watanabe one of Brazil’s most prestigious law firms, this is an extract from The Pharma Legal Handbook: Brazil, which can be purchased for GBP 119, here.    1. What are the…